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Summary: Low density lipoprotein (LDL), modified by chemical or biological means, was shown to induce
macrophage cholesterol accumulation. The cholesterol and protein contents of LDL were decreased (by 10
and 15%, respectively) by incubation of the LDL for 2 h at 37 °C with normal washed platelet Suspension or
with platelet-conditioned medium; these decreases were not affected by platelet activation. The platelet-
modified LDL caused a greater increase (by up to 15%) in collagen-induced, in vitro platelet aggregation
than control LDL. Incubation of mouse peritoneal macrophages with platelet-modified LDL for 18 h at 37 °C
resulted in an elevation of the macrophage cholesterol ester content (by 35 — 50%) s well s an increase in
the cholesterol esterification rate (by 40 — 70%), compared with the effect of control LDL. Macrophage
cholesterol synthesis, however, was significantly decreased (by 40 — 50%), compared with the effect of control
LDL. The effect of LDL treated by platelet-conditioned medium was similar to that of platelet-modified
LDL. The effect of platelet-modified LDL on macrophage cholesterol esterification was maximal within 24 h
of incubation, and it was not significantly affected by Inhibition of cholesterol synthesis. The platelet-modified
LDL was taken up by the macrophages in a saturable fashion and its uptake was competitively inhibited by
LDL, but not by acetylated LDL. We conclude that platelet-modified LDL interacts with the LDL receptor
and induces macrophage cholesterol accumulation. Since the modified lipoprotein induces in vitro foam cell
fprmation and platelet activation, platelet-modified LDL could be considered to be pro-atherogenic.
Introduction chqlesterol ester is hydrolysed to free cholesterol by
Λ>Γ - u i * i ' 1 4 . · · · „ acid lipase and then transferred to the cytoplasm. InMacrophage cholesterol accumulation is a prominent - ; . ' , r , ,' , . 4 ' ., .i T A . .. r,, Λ t ' . Γ · ,„N the cytoplasm, the free cholesterol is estenfied by acylearly charactenstic of the atherosclerotic lesion (1). A i 1 1 * ί j™ r ^ . ,.~ . . . .+ .^ . ' coenzynae A cholestef l acyltransferase or transferredPlasma hpoprotems modified in vitro, either chemi- ' ' , t . , ,„ , Γ ι *· " t " · i · n -u · ^ ^ v i to the plasma membrane, where it can be removedcally by acetylation, or biologically by endothehal or , . , A , . L. t , ·, ,·*u i n il u t * " " ^Υ cholesterol acceptors such s high density lipopro-smooth muscle cells, have been shown to cause mac- - ™ . A ^ , . , . , ., - , . , t .. ,Λ ·>\ n \ + i tem· The influx of cholesterol into the macrophagesrophage cholesterol accumulation (l — 3). Cholesterol ' . . , . , . . ,. „ , , , , , -, ,. t. Λ . , .. ... results in Inhibition of cellular cholesterol synthesisaccumulation in macrophages after incubation with , , , . . r , „ , , . Λ ,Λ·Γ Λ ι Λ ·*. r - * · /τ τ^τ \ · Λ ι* anc* tous, in the regula on of the cellular cholesterolmodified low density lipoprotein (LDL) is the result' r ' - , f. .- -r- * content.of hpoprotein interaction with specific receptors
which differ firom the native LDL receptor (4). After Modified lipoprotein causes the accumulation of cho-
receptor-mediated endocytosis, the lipoprotein is lesterol ester in macrophages, thus leading to foam
transferred to the lysosomal compartment, where the cell fonnation (l — 3). Since platelets are involved in
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thc atherosclerotic proccss (5) and interact with
plasma lipoproteins (6), with the vessel wall and with
macrophages (7), platelet-modified LDL, if formed in
vivo, may be of importance in the pathogenesis of
atherosclerosis. Recently we have shown that platelets
can modify LDL composition in vitro (8). The present
study was undertaken in order to study the biological
characteristics of platelet-modified LDL formed in
vitro, in two distinct mechanisms involved in the
atherogenic process: macrophage cholesterol accu-
mulation and platelet activation.
removal by centrifugation at 1500g for 10 min. LDL (450 mg
of protein per litre) was then added to thc platelet-conditioned
medium and incubated for 2 h at 37 °C. Simiiarly, I25I-labeIled
LDL was prcparcd in the presence of 10 mg/1I25I-labelled LDL.
In some experimerits, platelet-conditioned medium was pre-
pared from washed platelets activated by the addition of 5 · l O3
units per litre thrombin fof the entire incubation period. The
platelet-conditioned medium was treated with 5 · 1 3 units per
litre hirudin to remove the thrombin. . f
After incubation of platelet-conditioned medium with LDL, the
LDL was reisolated äs described for the platelet-modified LDL
System. Platelet-conditioned medium alone, incubated without
LDL, was also studied for its effect on macrophage cholesterol
metabolism.
Methods
Plalelet prepara t ion
Venous blood was collected after a 14h fast from healthy
subjects who had taken no medication for at least 3 weeks
preceding the study. Blood was taken into acid citrate dextrose
(2.5 g/l citric acid, 25 g/l sodium citrate, and 20 g/l dextrose)
in a 6: l volume ratio. Platelet-rich plasma was prepared by
low-speed centrifugation at 200 £ for 10 min at 23 °C. Washed
platelets were prepared from the platelet-rich plasma. Acetic
acid (10 mmol/1) was added to the platelet-rich plasma, which
was then centrifuged at 1500g for 10 min. The supernatant
was removed and the platelet pellet resuspended in Hepes buffer
(5 mmol/1 Hepes. 137 mmol/1 sodium Chloride, 2.7 mmol/l po-
tassium Chloride, 1.2 mmol/1 magnesium chloride, 12 mmol/1
sodium bicarbonate, 0.4 mmol/1 sodium biphosphate, and 0.6
mmol/1 glucose, pH 7.4) at a platelet concentration of 1012/1.
Lipoproteins
Blood was drawn into l g/l disodium EDTA. LDL was sepa-
rated by discontinuous density gradient ultracentrifugation (9)
and dialysed extensively against Hepes buffer in the presence
of 0.3 mmol/1 EDTA. The purity of LDL was analysed by
cellulose acetate electrophoresis and by Ouchterlony double
immunodiffusion and immunoelectrophoresis.'Lipoprotein pro-
tein concentration was determined using the -Rad protein
assay (10) (Bio-Rad Laboratories, Richmond, CA), and total
and free cholesterol concentrations by the method of Chlamori
& Henry (11). LDL was acetylated by repeated addition of
acetic anhydride/sodium acetate (12). LDL iodination was per-
formed by a modification of the iodine monochloride method
(13).
Incubation procedure
LDL (650 mg of protein per litre) was incubated with or without
washed platelets in Hepes buffer. A 4 ml platelel Suspension
was used in a concentration of 10I2/1 and incubated for 2 h at
37 °C. At the end of the incubation period the platelets were
removed by centrifugation at 1500g for 10 min, and LDL was
reseparated from the supernatant by ultracentrifugation at a
density of 1.210 kg/l. The appropriate control (LDL incubated
without platelets) was also included. The lipoproteins were
dialysed extensively against Hepes buffer containing 0.3 mmol/1
EDTA and analysed for protein and total, free and esterified
cholesterol concentrations. The platelet pellet contained LDL
äs determined by double immunodiffusion against anti-LDL.
Upon incubation of 125I-labelled LDL (10 mg/1) with washed
platelets, 10—16% of the radioactivity was found to beplatelet-
associated.
Platelet-conditioned medium was prepared from washed plate-
lets (their number equal to that used in platelet-modified LDL
formation) and incubated for 2 h at 37 °C, followed by platelet
Platelet aggregation
The lipoproteins (control and platelet-modified LDL) were
initially incubated with normal washed platelets (0.3 1012/1)
for 30 min at 37 °C. Platelet aggregation, measured äs a per-
centage of maximal amplitude, was studied with collagen
(l mg/1) äs aggregating agent (14), using the appropriate con^
trols without platelets, in a PAP-4 computerized aggregometer
(Bio-Data Corporation, Hatboro, PA).
Mouse peritoneal macrophages
Cells were harvested from the peritoneal fluid of 10 female
BALB/c mice (15—25 g) 4 days after intraperitoneal injection
into each mouse of 3 ml 24 g/l thioglycolate in saline (15). The
cells (10-20 106/mouse) were pooled, treated with 3 ml 8.3
g/l chloride, pH 7.4, and incubated for 5 min at 37 °C to remove
red blood cell contamination. The cells were washed and cen-
trifuged three times with phosphate-buiYered saline at 400 g for
10 min, then resuspended to 109/1 in Dulbecco's modified Eagles
medium containing horse serum (heat inactivated at 56 °C for
30 min, volume fraction 0.15), 100 kU/1 penicillin and 100 mg/1
streptomycin. The* cell Suspension was dispensed into 60 or 100
mm plastic Petri dishes and incubated in a hümidified 5% CO2
incubator for 2h. The dishes were washed once with 5ml
Dulbecco's modified Eagle's medium to remove nonadhefent
cells, and the monolayer was then incubated under similar
conditions for 18h. The medium was then changed to Dulbec-
co's modified Eagle's medium containing 2 g/l bovine serum
albumin, either without any additions (control) or with the
addition of the lipoproteins at various concentrations for 18 h.
At the end of the incubation period the cells were washed three
times with phosphate buffered saline, then collected in 2^4 ml
phosphate buffered saline using a rubber policeman and sedi-
mented at 400 g for 10 min. The cell pellet was resuspended in
1.2 ml distilled water and sonicated twice for 20 s at 80 W. An
aliquot of 0.1 ml was taken for protein determination, and
lipids were extracted from the remainder with Chloroform/
methanol (2 -h l, by vol.). Total and free macrophage choles-
terol (precipitated with digitonin), were then determined (11).
The cholesterol esterification rate in maerophages was meas-
ured äs the incorporation of pHJoleic acid into cellular choles-
teryl [3H]oleate äs described by Goldstern et al. (16). Macro-
phages were incubated in mediuni containing [3H]oleate com-
plexed with albumin (83 nmol oleate per mg albumin, 370
MBq/1; Amersham Radiochemical Centre, Amershani, Bucks.,
UK) at a final oleate concentration of 0.27 mmol/1, in the
presence or absence of lipoproteins. At the end of the incubation
period and after cell lipid extraction, lipids were separated by
thin-layer chromatography and developed in· hexane/ether/
acetic acid (80 -h 20 4- 1.5, by vol.). The cholesteryl ester spots
were visualized with iodine vapouf, scraped into vials containing
15 ml scintillation fluid, and counted in a beta-scintillation
counten
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Macrophage cholesterol synthesis was determined using 370
MBq/1 [3H]acetate, 1.25 mmol/1 (Amersham), in the cell incu-
bation System. After 18h of incubation, lipids were extracted
and separated s described above. Macrophage cholesterol syn-
thesis was measured s incorporation of [3H]acetate into
[3H]cholesterol. Degradation of I25l-labelled LDL by macro-
phagcs was studied s described elsewhere (12).
Statistics
For each experiment, duplicate or triplicate parallel cultures
were incubated. The Wilcoxon rank test was used to evaluate
the significance of the results.
Results
Two hours after the incubation of washed platelets in
Hepes buffer at 37 °C, a substantial loss (up to 20%),
of platelet lipids and protein had occurred without
changes in platelet aggregation (fig. 1). The addition
of bovine serum albumin or apyrase (which removed
released ADP) did not significantly affect the loss of
lipids and protein. Figure 2 demonstrates that various
aggregating agents also had only little effect on the
loss of platelet cholesterol and protein, except for
arachidonic acid, which caused 43% greater release
of total platelet cholesterol than in the control sam-
ples.
The lipid and protein losses were related to platelet
concentration and were not affected by the presence
of LDL in the medium (fig. 3). From these studies
(figs. l — 3) we chose the appropriate incubation con-
ditions for producing platelet-modified LDL.
When washed platelets (1012/1) were incubated with
650 mg/1 LDL for 2 h at 37 °C, followed by LDL
Separation by recentrifugation, the platelet-modified
LDL demonstrated a significant reduction of 15 —
25% in LDL protein and cholesterol (free and ester-
ified) content (fig. 4). These changes resulted in a
decreased ratio of free cholesterol to protein in the
modified LDL, compared with the control LDL (in-
cubated without platelets). Table l demonstrates that
the change in LDL composition caused by platelet-
conditioned medium derived from normal washed
platelets was similar to that caused by platelet sus-
pension (fig. 4). The absence of lactic dehydrogenase
activity in the incubation medium suggests that the
platelets did not release their cytoplasmic contents.
Similarly, when platelet-conditioned medium was de-
rived from thrombin-activated platelets (10 · l O3 U/l,
2 h at 37 °C, and then thrombin removal by 10 - 103
U/l hirudin), it caused a decrease in LDL cholesterol
and protein from 1.56 ± 0.34 and l .10 ± 0.26 mmol/1














Fig. l Influence of incubation time and medium composition
on platelet release of total cholesterol, phospholipids,
and protein, and on platelet aggregation. Washed plate-
lets (1012/1) were incubated in Hepes buffer for the
indicated time at 37 °C, with no addition (o), with the
addition of 3.5 g/l albumin (D), 100 mg/1 apyrase (Δ)
or both (V). At the end of the incubation period, the
platelets were removed by centrifugation at 1000g for
15 min, and the superaatant was used for analysis (mg/1)
of protein, cholesterol, and phospholipids. Platelet ag-
gregation induced by 5 μιηοΐ/ΐ ADP (o) or l mg/1 col-
lagen (·) was studied with a separate platelet Suspen-
sion. Each point represents the mean of three separate
results which differed by less then 4%.
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Fig. 2. Effect of various aggregating agents on release of platelet cholesterol and protein. Washed platelet (1012/1) were incubated
in Hepes buffer for 2 h at 37 °C, either alone (control) or with the addition of one of the following aggregating agents:
50 μιηοΐ/ΐ ADP, 0.1 g/l epinephrine, 5 mmol/1 arachidonic acid, 10 · 103 U/l thrombin, and 10 mg/1 Collagen. At the end
of the incubation period and after platelet removal by centrifugation, supernatant cholesterol and protein concentrations
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Fig. 3. Effect of platelet and LDL concentration on platelet cholesterol (o) and protein (·) release. Washed platelets. were
incubated m Hepes buffer for 2 h at 37 °C using either increasing platelet concentrations without LDL (left) or increasing
LDL concentrations with fixed platelet concentration of either (a) 0.5 or (b) 1.25 χ 1012/1 (right).
When washed platelets (300 · 109/1) were incubated
with increasing concentrations of platelet-modified
LDL for 30 min at 37 °C, collagen (l mg/l)-induced
platelet aggregation significantly increased (by 12%),
compared with the effect of control LDL (fig. 5).
Similarly, LDL modified by platelet-conditioned me-
dium also significantly increased normal washed
platelet aggregation (tab. 2). Platelet-conditioned me-
dium derived from thrombin activated platelets also
modified LDL in a siniilar way. At a cholesterol
J. Clin. Chem. Clin. Biochem//Vol. 27,1989 / No. l




















Fig. 4. Choleslerol and protein content of platelet-modified LDL (E3) compared with control LDL (D). For details, see Methods.
Results are mean ± SD of 15 experiments. *P < 0.01; **P < 0.02 (platelet-modified LDL versus control LDL). To convert
μ§/ιη1 to mmol/1 multiply the cholesterol value by 2.60, and the phospholipid value by 1.28.




















Results are mean ± SD of 12 experiments, expressed s mmol/1 for the lipids, mg/1 for protein and weight ratio for free
cholesterol/protein.






Fig. 5. Platelet aggregatipn induced by platelet-modified LDL
(a —D) and by cpntrol LDL (o—o). The lipoproteins
were incubated with normal washed-platelet Suspension
(300 χ 109/1) for 30 min at 37 °C, using three different
LDL concentrations, prior to analysis of platelet aggre-
gation induced by l mg/1 coHagen. Results are mean
± SD of seven experiments (P < 0.01 for platelet-mod-
. ified LDL vs. LDL).
concentration of 50 mg/1, LDL modified by platelet-
conditioned medium caused 93 + 8% aggregation,
compared with 81 + 6% for control LDL.
When mouse peritoneal macrophages were incubated
with platelet-modified LDL for 18h at 37 °C, the
macrophage total cholesterol content was significantly
elevated, compared with the effect of control LDL
(fig. 6). This cellular cholesterol elevation was due
mainly to elevation of the cholesterol ester fraction.
LDL modified by platelet-conditioned medium
caused a similar elevation in macrophage cholesterol
ester, but this was only 73% of the level achieved with
platelet-modified LDL (fig. 6). The cholesterol ester-
ification rate, measured s the amount of [3H]oleic
acid incorporated into cellular cholesterol ester, also
significantly increased in macrophages following in-
cubation with increasing concentrations of platelet-
Tab. 2. Effect of platelet-conditioned medium-treated LDL on platelet aggregation















* P < 0.01 (modified LDL versus control LDL) (n = 5).
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Fig. 6. Effect of platelet-modified LDL (π α) and platelet-
conditioned medium treated LDL (Δ, Δ) and control
LDL (ο, ο) on macrophage cholesterol content. Mouse
peritoneal macrophages (107/dish) were incubated for
18h at 37 °C in Dulbecco's modified Eagle's medium
containing 2 g/l bovine serum albumin and either LDL,
platelet-modified LDL. or platelet-conditioned me-
dium-treated LDL, using increasing lipoprotein concen-
trations. Macrophage total cholesterol (closed Symbols)
and free cholesterol (open Symbols) content were then
determined. Results represent mean ± SD of seven ex-
periments (for total cholesterol P < 0.01 for platelet-
modified LDL vs. control LDL).
modified LDL (flg. 7a); this was up to 70% more
than the effect of control LDL. LDL and both mod-
ified LDLs, when incubated with macrophages for
18 h, caused a reduction in mouse peritoneal macro-
phage cholesterol synthesis, measured s [3H]acetate
incorporated into cellular cholesterol (fig. 7b). The
decreases caused by both modified LDL however,
were 50% and 28% greater than th f caused by con-
trol LDL.
Similar results, although of lesser magnitude, were
obtained when LDL modified by platelet conditioned
medium was used instead of platelet-modified LDL
(fig. 7 a and 7b). Table 3 demonstrates that platelet-
conditioned medium derived from thrombin-activated
platelets caused the formation of a modified LDL,
which had an effect on mouse peritoneal macrophage
cholesterol metabolism similar to that of LDL mod-
ified by platelet-conditioned medium prepared from
nonactivated platelets (fig. 7). When acetyl-LDL (50
mg/1) was incubated with macrophages for 18h at
37 °C, we fo nd a dramatic increase of 350% in the
cellular cholesterol ester content and esterification,
and a 60% decrease in cellular cholesterol synthesis,
compared with controls containmg LDL.
The elevation in macrophage cholesterol esterification
rate by LDL and platelet-modified LDL was time






Fig. 7. InOuence of platelet-modified LDL and platelet-conditioned medium-treated LDL on macrophage cholesterol esterifieaticm
rate and on cholesterol synthesis. Mouse peritoneal macrophages were incubated with LDL (o), platelet-modified LDL
r r3uiP "l°x tl0ned medium-treate^ LDL (Δ) for 18 h at 37 °C in the presenee of 370 MBq/1 PHloleic acid (a) or
of [ H]acetate (b). After analysis of the cellular lipid extract by thin-layer chromatography, the radioactivity in the free
cholestero spot was determined. Results represent mean ± SD of six experiments (P < 0.01 for platelet-modified LDL
vs. control LDL). -
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For details see Incubation Procedure under Methods.
Results represent the mean of three experiments with a similar pattern and a maximal Variation of 8%.
(fig. 8). The macrophage cholesterol esterification rate
was not significantly affected by cellular cholesterol
biosynthesis Inhibition with 0.4 mg/1 mevinolin (fig.
8). Degradation of 125I-labeIled LDL modified by
platelet-conditioned medium showed saturable kinet-
ics in mouse peritoneai macrophages (fig. 9A), and
its degradation was competitively inhibited by native
LDL but not by acetyl LDL (fig. 9B). Both modified
LDLs and control LDL displayed similar mobilities
in immunoelectrophoretic analysis. On 2.5% SDS-
PAGE analysis no apolipoprotein B fragments were
found (although small molecular weight fragments
Ti'me of incubqtion Ch]
Fig. 8. Effect of time of incubation of macrophage with plate-
let-modified LDL (p, p) a_nd LDL (o, o) on cellular
cholesterol esteri cation, and the influence of mevino-
lin. Mevinolin inhibited cholesterol synthesis by niore
than 90%, s determined by the incorporation of
[3H]acetate into free cholesterol. Incubation was carried
out without (closed symbols) or with (open Symbols)
mevinolin (400 mg/1). Results represent mean ± SD of
4 experiments.
may not be detected by these gels). Platelet-condi-
tioned medium contained two major protein bands
corresponding to relative molecular masses of 60 000
and 100000. Platelet-modified LDL also inhibits the
degradation of 125I-labelled LDL modified by platelet-
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Fig. 9. Degradation of platelet-conditioned medium-treated
LDL by mouse peritoneai macrophages. !25I-labelled
LDL was incubated without or with platelet-condi-
tioned medium s described under Methods.
a) Macrophages were incubated with increasing concen-
trations of either 125I-labelled LDL (o-o) or platelet-
conditioned medium-treated 125I-labelled LDL (o-o,
165 counts/min · ̂ g) for 5 h at 37 °C prior to analysis
of LDL degradation.
b) 10 mg/1 of platelet-conditioned medium-treated 12SI-
labelled LDL were incubated with macrophages in the
presence of increasing concentrations of either LDL
(o-o) or acetylated LDL (o-o) for 5h at 37 °C
followed by analysis of the radiolabelled LDL degra-
dation.
Results represent the mean of 3 separate experiments.
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Following incubation of platelet-conditioned medium
(25 mg protein per litre) with normal washed platelets
(0.3 · 1012/1), Collagen (l mg/l)-induced platelet aggre-
gation was reduced from 76 + 12% to 65 ± 8%; a
similar effect was obtained with 50 g platelet-con-
ditioned medium protein per litre (p < 0.01).
Platelet-conditioned medium alone (not interacting
with LDL), when incubated with macrophages, in-
creased the cellular cholesterol content and esterifi-
cation, and reduced cellular cholesterol synthesis (tab.
4), in comparison with the control which contained
no additions; these effects, however, were less than
those caused by the lipoproteins (figs. 6, 7). The
addition of platelet-conditioned medium, together
with control LDL or LDL modified by platelet-con-
ditioned medium to the macrophages, results in an
additive effect (tab. 5), implying separate mechanisms
for cell cholesterol uptake induced by platelet-condi-
tioned medium and by the lipoproteins. The lipids
and proteins released from the platelet did not float
up at a density of 1.210 kg/l, but remained in the
infranatant.
Discussion
This study demonstrates that material released from
platelets, can influence two different biochemical
events. It can directly increase the macrophage cho-
lesterol content and reduce in vitro platelet aggrega-
tion, and it can also modify LDL in such a way that
the modified lipoprotein increases platelet aggregation
and causes cholesterol accumulation in mouse peri-
toneal macrophages.
Although it could be suggested that the effect of LDL
modified by plateletrconditioried medium on macro-
phage cholesterol metabolism is the r^sült of the ac-
tion of a factor in platelet-conditioned medium (which
may float together with the reisolated LDL), rather
than associated with the lipoprotein, our data suggest
two separate mechanisms for platelet-conditioned me-
dium and LDL modified by platelet-conditioned me-
dium.
We were able to show that the lipids and protein
released from platelets did not float at a density of
1.210 kg/l and thus the platelet-conditioned medium
lipids and protein could not be directly linked to the
effect of the lipoproteins. Furthermore, when platelet-
conditioned medium was incubated with macrophages
in the presence of control LDL or in the presence of
LDL modified by platelet-conditioned medium the
cholesterol content of the cells was in fact a restilt of
an additive effect, implying that platelet-conditioned
medium contributed to the macrophage cholesterol
content independently of the contribution of LDL
modified by platelet-conditioned medium. Platelet-
conditioned medium also displayed opposing effects
to that of LDL modified by platelet-conditioned me-
dium on in vitro platelet aggregation, suggesting again
that LDL modified by platelet-conditioned medium
Tab. 4. The effect of platelet-conditioned medium on macrophage cholesterol metabolism.
Platelet-conditioned medium



















Results are the mean ± SD of five experiments.
* P < 0.02 (platelet-conditioned medium versus controi)




-f platelet-conditioned medium (25 mg protein per litre)
4- control LDL (25 mg protein per litre)
-h platelet-conditioned medium + control LDL
+ platelet-conditioned medium-treated LDL (25 mg protein per litre)







Results are the mean of duplicates which varied by less than 2%
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and platelet-conditioned medium act separately
through different mechanisms.
Macrophages possess significant quantities of LDL
receptors capable of binding LDL (l 7). Macrophage
cholesterol accumulation following incubation with
control LDL could be the result of the expression of
LDL binding sites in response to the Stimulation of
the mice with thioglycolate. It could be the result of
an unusual apolipoprotein B, E (LDL) receptor (17)
and also of a non-receptor interaction between LDL
and macrophages. LDL modified by platelet-condi-
tioned medium substantially increased the macro-
phage cholesterol content and esterification rate, and
decreased cellular cholesterol synthesis, compared
with control LDL. A similar pattern has been de-
scribed for chemically and biologically modified LDL
(18-20). On the other hand endothelial-cell-modified
LDL was formed only in the presence of the cells but
not in the presence of the cell-conditioned medium
(20). However, unlike the other modified LDL prep-
arations, LDL modified by platelet-conditioned me-
dium reacts with the LDL receptor and not with the
scavenger binding sites äs suggested from the com-
petition experiments of 125I-labelled LDL modified by
platelet-conditioned medium with native LDL and
acetyl LDL. The greater ability of LDL modified by
platelet-conditioned medium to cause macrophage
cholesterol aecumulation, compared with the effect of
control LDL (even though they both bind to the same
receptors) could be attributed to increased receptor
uptake. This, in turn, may be due to the affinity of
LDL modified by platelet-conditioned medium for
the LDL receptors, compared with control LDL. Fur-
thermore, the intracellular metabolism of cholesterol
may differ, depending on whether it is derived from
LDL pr from LDL modified by platelet-conditioned
medium.
Activated platelets have been shown to release lipid-
protein particles with platelet factor 3 like activity
(21), and it was also demonstrated recently that mem-
brane microvesicles could be formed from platelets
(22). The lipids and protein which are lost from the
platelets are very probäbly originated from the plate-
let gramiles and are released to the medium during
incubation. The incubation itself could activate the
platelets and this might be the reason that activation
of platelets with various aggregating agents did not
cause further modifications of the lipoprotein. We
have demonstrated that lipids and protein released
from platelets can affect lipoprptein composition (23).
It was also shown (7, 24) that platelet activation
results in the release of lipids which in turn affect
cholesterol accumulation in smooth muscle cells and
in macrophages. Similarly, platelet-conditioned me-
dium in our study was found to increase the macro-
phage cholesterol content.
No significant changes were found in the thiobarbi-
turic acid reactive material expressed äs malondialde-
hyde concentrations, suggesting that LDL oxidation
was not induced in LDL modified by platelet-condi-
tioned medium formation and that LDL modified by
platelet-conditioned medium is not malondialdehyde-
LDL (19). Some of the platelet material associated
with LDL may include some aggregation-promoting
substances released from the platelet granules, and
this could account for the increased in vitro platelet
aggregation. Platelets possess specific binding sites for
LDL (6), and the decrease of LDL constituents in
LDL modified by platelet-conditioned medium could
be related in part to LDL binding to a substance or
substances released from the platelets. Thus, platelet-
LDL interaction could result in removal of some
subset of LDL, leaving a "hyperactive" subset beliind.
The materials released from the platelets and respon-
sible for the modification of the LDL molecule are
possibly platelet lipase, protease or lipid transferase.
Alternatively, this platelet-released material might ac-
tivate LDL-associated protease, phospholipase or
other LDL-bound enzymes (25).
The effect of platelet-modified LDL on macrophage
cholesterol metabolism was similar to that already
shown for other LDL preparations (26); LDL uptake
by the cells results in lysosomal cholesterol ester hy-
drolysis, followed by reesterification and a parallel
reduction in cell cholesterol synthesis. The Inhibition
of cholesterol synthesis with mevinolin did not affect
cell cholesterol esterification, suggesting that the cho-
lesterol ester of LDL modified by platelet-conditioned
medium itself (and not the cholesterol derived from
biosynthesis) contributed to macrophage cholesterol
accumulation.
Macrophage cholesterol accumulation and platelet
activation represent parameters of atherogenicity (27);
since LDL modified by platelet-conditioned medium
affects both macrophages and platelets, it could there-
fore be regarded äs possessing atherogenic properties.
Platelets are found in abundance in the area of the
atherosclerotic plaque; thus LDL modified by plate-
let-conditioned medium may be formed in vivo under
certain pathological conditions and the platelet-mod-
ified LDL may then accelerate the atherosclerotic
process.
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